STT |
Code |
Test Items |
TAT |
Specimen (mL) |
Method |
1 |
Z020 |
AML1/ETO (RUNX1/RUNX1T1) gene rearrangement [RT-PCR] |
7 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
RT-nested
PCR |
2 |
S875 |
APOE genotype [Real-time PCR] |
7 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
PCR with
hybridization |
3 |
S853 |
BCR/ABL1 Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
4 |
M345 |
BRAF gene mutation [Real-time PCR] |
6 days |
Puncture aspiration specimen (FNA) 0.2
Paraffin block &
1 H&E slide
Unstained slide 10 μm thickness 5 pieces &
1 H&E slide |
Real-time
PCR |
5 |
L446 |
BRAF gene mutation [Sequencing] |
8 days |
Paraffin block &
1 H&E slide
Unstained slide
5 sheets of 10 μm thickness &
1 H&E slide |
Sanger
sequencing |
6 |
L535 |
CALR gene mutation [Fragment analysis & Sequencing] |
13 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
Sanger
sequencing |
7 |
B537 |
CBFB/MYH11 Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
8 |
N915 |
CBFB/MYH11 gene rearrangement [RT-PCR] |
6 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
RT-nested
PCR |
9 |
M347 |
CEBPA gene mutation [Sequencing] |
17 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
Sanger
sequencing |
10 |
P030 |
CEL DX panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
11 |
K210 |
Centromere 12 [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
12 |
B539 |
Centromere 8 [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
13 |
S351 |
Ch (Hematologic BM) |
16 days |
Specialized tool BM 5.0ml |
Cell culture |
14 |
S460 |
Ch (Hematologic PB) |
16 days |
Heparin WB 5.0ml
Specialized tool PB 5.0ml |
Cell culture |
15 |
L780 |
Ch(PB, General) |
13 days |
Heparin WB 5.0ml |
Cell culture |
16 |
S456 |
Ch(PB, High Resolution) |
13 days |
Heparin WB 5.0ml |
Cell culture |
17 |
B533 |
Chromosome 13q (RB1, 13q14) [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
18 |
B574 |
Chromosome 1q21 (1p32/1q21) [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
19 |
B545 |
Chromosome 20q (20q12) [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
20 |
B547 |
Chromosome 5q (5q31) [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
21 |
B546 |
Chromosome 7q (7q22/7q31) [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
22 |
N040 |
c-KIT gene mutation (BM) [Sequencing] |
18 days |
EDTA BM 3.0ml |
Sanger sequencing |
23 |
X757 |
c-KIT gene mutation (WB) [Sequencing] |
18 days |
EDTA WB 3.0ml |
Sanger sequencing |
24 |
X348 |
c-KIT gene mutation (Tissue) [Sequencing] |
13 days |
"Paraffin block &
1 H&E slide
Unstained slide
5 sheets of 10 μm thickness &
1 H&E slide" |
Sanger sequencing |
25 |
X795 |
Cri-du-chat syndrome (amniotic fluid) [FISH] |
18 days |
Amniotic Fluid 20.0ml |
FISH |
26 |
B542 |
Cri-du-chat syndrome, del(5p) [FISH] |
12 days |
Heparin WB 3.0ml
Heparin BM 3.0
ml |
FISH |
27 |
M341 |
CYP2C19 Major Polymorphism [Sequencing] |
8 days |
EDTA WB 3.0ml |
Sanger sequencing |
28 |
M340 |
CYP2C9 Major Polymorphism [Sequencing] |
8 days |
EDTA WB 3.0ml |
Sanger sequencing |
29 |
X798 |
Digeorge I, CATCH22 (amniotic fluid) [FISH] |
18 days |
Amniotic fluid
20.0ml |
FISH |
30 |
B536 |
Digeorge I, CATCH22, del(22q11.2) [FISH] |
12 days |
Heparin WB 5.0ml |
FISH |
31 |
X031 |
E2A/PBX1 (TCF3/PBX1) gene rearrangement [RT-PCR] |
7 days |
EDTA WB 6.0ml
EDTA BM 3.0ml |
RT-nested
PCR |
32 |
N537 |
EGFR (cell-free DNA) [Real-time PCR] |
7 days |
|
Real-time PCR |
33 |
L694 |
EGFR (Tissue) [PNA clamping Real-time PCR] |
7 days |
Paraffin block &
1 H&E slide
Unstained slide
5 sheets of 10 μm thickness &
1 H&E slide |
Peptide nucleic acid mediated
Real-time PCR clamping
method |
34 |
M040 |
EGFR (Tissue) [Pyrosequencing] |
7 days |
Paraffin block &
1 H&E slide
Unstained slide
5 sheets of 10 μm thickness &
1 H&E slide |
PCR &
pyrosequencing |
35 |
B559 |
ETV6/RUNX1 (TEL/AML1) Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
36 |
M683 |
Factor V Leiden R534Q mutation [Real-time PCR] |
7 days |
EDTA WB 3.0ml |
PCR with hybridization |
37 |
N042 |
FGFR1 Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
38 |
B661 |
FGFR3 gene Major mutation (Achondroplasia) [Sequencing] |
10 days |
EDTA WB 5.0ml |
Sanger sequencing |
39 |
B577 |
FIP1L1/PDGFRA Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
40 |
M745 |
FLT3-ITD mutation [Fragment analysis & Sequencing] |
17 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
Sanger sequencing &
PCR fragment analysis |
41 |
M746 |
FLT3-TKD mutation [Sequencing] |
17 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
Sanger sequencing |
42 |
M019 |
GLA gene mutation (Fabry disease) [Sequencing] |
24 days |
EDTA WB 3.0ml |
Sanger sequencing |
43 |
B341 |
HBB gene mutation (β-Thalassemia) [Sequencing] |
18 days |
EDTA WB 6.0 |
Sanger sequencing |
44 |
K579 |
HER2 FISH |
8 days |
Paraffin block &
H&E slide
4 unstained slides
& H&E slide |
FISH |
45 |
Z131 |
HLA-B51 |
6 days |
EDTA WB 3.0ml |
PCR-SSP |
46 |
C952 |
IGH Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0
ml |
FISH |
47 |
L020 |
IGH gene rearrangement (Tissue) |
13 days |
paraffin block
Unstained slide
4 sheets of 20 μm thickness &
1 H&E slide |
PCR-PAGE |
48 |
P798 |
IGH gene rearrangement (WB/BM) |
13 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
PCR-PAGE |
49 |
B548 |
IGH/BCL2 Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
50 |
B558 |
IGH/CCND1 Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
51 |
B572 |
IGH/FGFR3 Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
52 |
B573 |
IGH/MAF Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
53 |
N043 |
IGH/MAFB Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
54 |
H978 |
IGH/MYC/CEP 8 Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
55 |
M031 |
Imatinib drug resistance (Major BCR/ABL1) [Sequencing] |
13 days |
EDTA WB 3.0ml
EDTA BM 1.5ml |
Sanger sequencing |
56 |
M049 |
JAK2 gene Exon 12 mutation [Sequencing] |
10 days |
EDTA WB 3.0ml |
Sanger sequencing |
57 |
Z041 |
JAK2 V617F mutation [Real-time PCR] |
7 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
Allelespecific PCR |
58 |
M562 |
KRAS gene mutation [Sequencing] |
8 days |
"Paraffin block &
1 H&E slide
Unstained slide
5 sheets of 10 μm thickness &
1 H&E slide" |
Sanger sequencing |
59 |
M563 |
KRAS gene major mutation [Pyrosequencing] |
6 days |
"Paraffin block &
1 H&E slide
Unstained slide
5 sheets of 10 μm thickness &
1 H&E slide" |
PCR & pyrosequencing |
60 |
K157 |
Major BCR/ABL1 (b2a2, b3a2) quantitative (IS) [Real-time PCR] |
7 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
Real-time RT-PCR |
61 |
M555 |
Major BCR/ABL1 [RT-PCR] |
7 days |
EDTA WB 5.0ml
EDTA BM 3.0ml |
RT-nested PCR |
62 |
M556 |
Minor BCR/ABL1 [RT-PCR] |
7 days |
EDTA WB 5.0ml
EDTA BM 3.0ml |
RT-nestedPCR |
63 |
K437 |
MDM2 FISH |
8 days |
Paraffin block &
H&E slide
Unstained slide
Chapter 4 & H&E slide |
FISH |
64 |
B553 |
MLL (KMT2A) Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
65 |
L665 |
MPL gene W515 mutation [Sequencing] |
13 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
Sanger sequencing |
66 |
K470 |
MSI (Microsatellite Instability) |
8 days |
Paraffin block
Unstained slide
4 sheets of 20 μm thickness &
1 H&E slide |
Multiplex PCR &
capillary electrophoresis |
67 |
N041 |
MTHFR A1298C [Real-time PCR] |
9 days |
EDTA WB 3.0ml |
PCR with hybridization |
68 |
M672 |
MTHFR C677T [Real-time PCR] |
9 days |
EDTA WB 3.0ml |
PCR with hybridization |
69 |
Z226 |
NOTCH3 gene mutation (CADASIL) [Sequencing] |
17 days |
EDTA WB 5.0ml |
Sanger sequencing |
70 |
P538 |
NOTCH3 gene, Familial mutation (CADASIL) [Sequencing] |
10 days |
EDTA WB 3.0ml |
Sanger sequencing |
71 |
M346 |
NPM1 gene mutation [Sequencing] |
10 days |
EDTA WB 5.0ml
EDTA BM 3.0ml |
Sanger sequencing |
72 |
M029 |
NRAS gene mutation [Sequencing] |
8 days |
Paraffin block &
1 H&E slide
Unstained slide
5 sheets of 10 μm thickness &
1 H&E slide |
Sanger sequencing |
73 |
M030 |
NRAS gene major mutation [Pyrosequencing] |
6 days |
Paraffin block &
1 H&E slide
Unstained slide
5 sheets of 10 μm thickness &
1 H&E slide |
PCR & pyrosequencing |
74 |
B570 |
p16, 9p21 [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
75 |
L025 |
PDGFRA gene mutation [Sequencing] |
13 days |
Paraffin block
Unstained slide
5 sheets of 10 μm thickness |
Sanger sequencing |
76 |
S541 |
PDGFRB Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
77 |
S481 |
PML/RARA Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
78 |
G229 |
PML/RARA quantitative (BM) [Real-time PCR] |
9 days |
EDTA BM 5.0ml |
Real-time RT-PCR |
79 |
M747 |
PML/RARA quantitative (WB) [Real-time PCR] |
9 days |
EDTA WB 5.0ml |
Real-time RT-PCR |
80 |
H188 |
PML/RARA qualitative (BM) [RT-PCR] |
6 days |
EDTA BM 3.0ml |
RT-nested PCR |
81 |
S884 |
PML/RARA qualitative (WB) [RT-PCR] |
6 days |
EDTA WB 3.0ml |
RT-nested PCR |
82 |
M678 |
Post-SCT (Stem Cell Transplantation) engraftment analysis |
14 days |
EDTA WB 3.0ml |
PCR-PAGE |
83 |
M677 |
Pre-SCT (Stem Cell Transplantation) |
14 days |
Patient & donor respectively
EDTA WB 3.0ml
Patient & donor respectively
EDTA-BM 3.0ml |
PCR-PAGE |
84 |
X796 |
Prader-Willi/Angelman syndrome (amniotic fluid) [FISH] |
10 days |
Amniotic fluid 20.0ml |
FISH |
85 |
B556 |
Prader-Willi/Angelman syndrome, del(15q11) [FISH] |
18 days |
Heparin WB 5.0ml |
FISH |
86 |
M684 |
Prothrombin G20210A mutation [Real-time PCR] |
10 days |
EDTA WB 3.0ml |
PCR with hybridization |
87 |
M012 |
QF-Ch (AF) |
14 days |
Amniotic fluid 20.0ml |
QF-PCR & culture |
88 |
M008 |
QF-PCR 21 (Down rapid.) |
5 days |
Amniotic fluid 20.0ml |
PCR-PAGE |
89 |
M009 |
QF-PCR 21,18,13 (Aneu.) |
5 days |
Amniotic fluid 20.0ml |
PCR-PAGE |
90 |
M011 |
QF-PCR 21,18,13,X,Y (Aneu.) |
5 days |
Amniotic fluid 20.0ml |
PCR-PAGE |
91 |
L002 |
RNF213 gene R4810K mutation (Moyamoya disease) [Sequencing] |
10 days |
EDTA WB 3.0ml |
Sanger sequencing |
92 |
L848 |
ROS1 FISH |
8 days |
Paraffin block &
H&E slide
Unstained slide
Chapter 4 & H&E slide |
FISH |
93 |
L781 |
RPN1/MECOM Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
94 |
S869 |
RUNX1/RUNX1T1 (AML1/ETO) Fusion Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
95 |
Z906 |
SCA 1 gene mutation (Spinocerebellar ataxia 1) |
17 days |
EDTA WB 3.0ml |
PCR-PAGE |
96 |
N232 |
SCA 1,2,3,6,7 |
17 days |
EDTA WB 3.0ml |
PCR-PAGE |
97 |
Z907 |
SCA 2 gene mutation (Spinocerebellar ataxia 2) |
17 days |
EDTA WB 3.0ml |
PCR-PAGE |
98 |
Z908 |
SCA 3 gene mutation (Spinocerebellar ataxia 3) |
17 days |
EDTA WB 3.0ml |
PCR-PAGE |
99 |
Z909 |
SCA 6 gene mutation (Spinocerebellar ataxia 6) |
17 days |
EDTA WB 3.0ml |
PCR-PAGE |
100 |
Z910 |
SCA 7 gene mutation (Spinocerebellar ataxia 7) |
17 days |
EDTA WB 3.0ml |
PCR-PAGE |
101 |
S160 |
SRY gene (Sex determining Region Y) [PCR] |
10 days |
EDTA WB 5.0ml |
PCR |
102 |
L023 |
TCR gamma gene rearrangement (Tissue) |
13 days |
Paraffin block
Unstained slide
4 sheets of 20 μm thickness &
1 H&E slide |
PCR-PAGE |
103 |
P799 |
TCR gamma gene rearrangement (WB/BM) |
13 days |
EDTA WB 3.0ml
EDTA BM 3.0
ml |
PCR-PAGE |
104 |
S893 |
TEL/AML1 (ETV6/RUNX1) gene rearrangement [RT-PCR] |
6 days |
EDTA WB 3.0ml
EDTA BM 3.0
ml |
RT-nested PCR |
105 |
N956 |
TERT gene promoter mutation [Sequencing] |
17 days |
Unstained slide
5 sheets of 10 μm thickness
& 1 H&E slide |
Sanger sequencing |
106 |
P476 |
TGFBI gene R124H mutation (Corneal dystrophy, Avellino type) [Sequencing] |
10 days |
EDTA WB 3.0ml |
Sanger sequencing |
107 |
B576 |
TP53 Gene [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0
ml |
FISH |
108 |
S233 |
TPMT Major Polymorphism [Sequencing] |
13 days |
EDTA WB 3.0ml |
Sanger sequencing |
109 |
C955 |
Trisomy 18 [FISH] |
4 days |
Amniotic fluid 10.0ml
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
110 |
C954 |
Trisomy 21 & 13 [FISH] |
4 days |
Amniotic fluid 10.0ml
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
111 |
N131 |
TTR gene mutation (Hereditary Transthyretin Amyloidosis) [Sequencing] |
18 days |
EDTA WB 3.0ml |
Sanger sequencing |
112 |
N476 |
UGT1A1 gene mutation (Crigler-Najjar syndrome) [Sequencing] |
17 days |
EDTA WB 3.0ml |
Sanger sequencing |
113 |
P535 |
UGT1A1 genotype, Major variants (irinotecan sensitivity) [Sequencing] |
12 days |
EDTA WB 3.0ml |
PCR & pyrosequencing |
114 |
M342 |
VKORC1 genotype [Sequencing] |
10 days |
EDTA WB 3.0ml |
Sanger sequencing |
115 |
X797 |
Williams syndrome (amniotic fluid) [FISH] |
18 days |
Amniotic fluid 20.0ml |
FISH |
116 |
B560 |
Williams syndrome, del(7q11) [FISH] |
12 days |
Heparin WB 5.0ml |
FISH |
117 |
B561 |
XY [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
118 |
S557 |
Parentage test |
6 days |
EDTA WB 3.0ml
oral swab |
PCR-PAGE |
119 |
N955 |
NUDT15 genotype [Sequencing] |
17 days |
EDTA WB 3.0ml |
Sanger sequencing |
120 |
K578 |
ALK FISH |
8 days |
Paraffin block & H&E slide
4 unstained slides & H&E slide |
FISH |
121 |
P358 |
ALL 2 items panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
122 |
N046 |
ALL Panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
123 |
P784 |
CLL 3 items panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
124 |
S354 |
Ch CVS-D |
8 days |
CVS 20.0~40.0 mg |
Cell culture |
125 |
S353 |
Ch CVS-L |
18 days |
CVS 20.0~40.0 mg |
Cell culture |
126 |
S355 |
Ch (Abortus) |
18 days |
Abortus 5.0~10.0 g |
Cell culture |
127 |
S352 |
Ch (AF) |
14 days |
Amniotic Fluid
20.0ml |
Cell culture |
128 |
S534 |
Ch (Cord) |
10 days |
Heparin
Cord blood 3.0 |
Cell culture |
129 |
M333 |
MPN gene mutations (JAK2 V617F/Exon 12, CALR, MPL W515K/L) |
13 days |
EDTA WB 3.0ml
EDTA BM 3.0ml |
Sanger sequencing |
130 |
P033 |
ITP/AA Dx panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
131 |
P034 |
CLL Dx panel [FISH] |
7 days |
"Heparin WB 5.0ml
Heparin BM 5.0ml" |
FISH |
132 |
N049 |
CLL Panel [FISH] |
7 days |
"Heparin WB 5.0ml
Heparin BM 5.0ml" |
FISH |
133 |
M053 |
Hemavision, Acute leukemia gene rearrangement profile [RT-PCR] |
8 days |
EDTA WB 8.0ml
EDTA BM 3.0ml |
RT-nested PCR |
134 |
C957 |
MDS Panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
135 |
P028 |
MDS Dx panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
136 |
N047 |
AML Panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
137 |
P024 |
AML 5 items panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
138 |
P035 |
Lymphoma panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
139 |
P032 |
CMPN-1 Dx panel [FISH] |
7 days |
"Heparin WB 5.0ml
Heparin BM 5.0ml" |
FISH |
140 |
P031 |
CMPN Dx panel [FISH] |
7 days |
"Heparin WB 5.0ml
Heparin BM 5.0ml" |
FISH |
141 |
P026 |
ALL Dx panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
142 |
P025 |
AML 6 items panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
143 |
P359 |
AML 7 items panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
144 |
N048 |
MM Panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
145 |
P029 |
MM Dx panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
146 |
P027 |
ABL Dx panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |
147 |
P023 |
AML 10 items panel [FISH] |
7 days |
Heparin WB 5.0ml
Heparin BM 5.0ml |
FISH |